Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy response
Article in BMC Cancer (August 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in BMC Cancer (August 2024)
Article in Biomolecules (July 2024)
Article in Frontiers in Immunology (July 2024)